TransCode Therapeutics (RNAZ US)

Health Care • United States

TransCode Therapeutics, Inc. operates as a biotech company. The Company focuses on developing a proprietary delivery system that has been repurposed to safely deliver optimized therapeutic oligonucleotides to genetic targets in tumors and metastases. TransCode Therapeutics serves customers worldwide.

Refresh

No events found

We’ll display events we find for TransCode Therapeutics here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00